| Page | ||||||
|---|---|---|---|---|---|---|
| Trustees' annual report (incorporating |
the | director's | report) | |||
| Independent examiner's report |
to the | trustees | ||||
| Statement offinancial |
activities | (including | income and | |||
| expenditure account) |
||||||
| Statement offinancial |
position | |||||
| Notes to the financial | statements |
| Registered | charity | name | name | Arab Scientific Community | Arab Scientific Community | Arab Scientific Community | Organisation | |
|---|---|---|---|---|---|---|---|---|
| Charity registration | number | 1134734 | ||||||
| Company | registration | number | 07030880 | |||||
| Principal office and | registered | 7 Redbridge | Lane East | |||||
| office | liford | |||||||
| Essex IG4 | 5ET | |||||||
| The trustees | ||||||||
| Dr M Al-Rabban | ||||||||
| Al Rabban | Foundation | for | Studies | |||||
| &Research | ||||||||
| Company | secretary | Dr M Al-Rabban | ||||||
| Independent | examiner | R C Patel, FCA FCCA | ||||||
| 7 Redbridge | Lane East | |||||||
| Redbridge, | llford | |||||||
| Essex IG4 5ET |
| 2020 | 2020 | 2019 | ||||
|---|---|---|---|---|---|---|
| Unrestricted | ||||||
| funds | Total funds | Total funds | ||||
| Note | $ | $ | $ | |||
| Income and endowments | ||||||
| Donations and |
legacies | 5 | 199,805 | 199,805 | 158,022 | |
| Total income | 199,805 | 199,805 | 158,022 | |||
| Expenditure | ||||||
| Expenditure on |
charitable | activities | 6,7 | 194,741 | 194,741 | 173,917 |
| Total expenditure | 194,741 | 194,741 | 173,917 | |||
| Net income/(expenditure) | and net movement | in funds | 5,064 | 5,064 | (15,895) | |
| Reconciliation | offunds | |||||
| Total funds brought forward |
5,580 | 5,580 | 21,475 | |||
| Total funds carried forward | 10,644 | 10,644 | 5,580 |
| 2020 | 2019 | ||||
|---|---|---|---|---|---|
| Note | $ | ||||
| Current assets | |||||
| Debtors | 12 | 12,030 | 6,630 | ||
| Creditors: amounts | falling due within one year | 13 | 1,386 | 1,050 | |
| Net current assets | 10,644 | 5,580 | |||
| Total assets less current liabilities | 10,644 | 5,580 | |||
| Net assets | 10,644 | 5,580 | |||
| Funds ofthe charity Unrestricted funds |
10,644 | 5,580 | |||
| Total charity funds | 10,644 | 5,580 |
| Donations | and legacies | Unrestricted Total Funds Funds 2020 $:$ |
Unrestricted Total Funds Funds 2020 $:$ |
Unrestricted Funds - - $ |
Unrestricted Funds - - $ |
Total Funds 2019 . $ |
Total Funds 2019 . $ |
||
|---|---|---|---|---|---|---|---|---|---|
| Donations Donations |
and contributions | 199,805 | 199,805 | - | 158,022 | - " | .158;022 | ||
| Expenditure | on charitable | activities | by fund type | ||||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||||||
| Funds | 2020 | Funds | ' | 2019 | |||||
| $ | $ | $ | ' | $ | |||||
| Research Support costs |
193,250 1,491 |
193,250 1,491 |
172,810 . 1;107 |
. ' |
172,810 ' 1,107 |
||||
| 194,741 | 194,741' | 'l73,917 | "173;917 |
| Expenditure | on charitable ac |
tivities by activity typ |
e | |||
|---|---|---|---|---|---|---|
| Activities | ||||||
| undertaken | Tdtal funds | Total fund | ||||
| directly | Support | costs | 2020 | 2019 | ||
| Research | $ 193,250 | $ | $ 193,250 | $ 172,810 | ||
| Governance | costs | 1,491 | 1,491 | 1,107 | ||
| 193,250 | 1,491 | 194,741 | 173',917 |
| 8. | Analysis of | support cost | s | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Analysis of |
|||||||||
| support costs activity1 $. . |
Total 2020, $ |
Total 2019 $. . . |
|||||||
| Governance | costs | 1,491 | 1,491 | . | — | 1.,107 | |||
| 9. | Independent | examination | fees | ||||||
| 2020 | '201'9 | ||||||||
| $ | $ | ||||||||
| Fees payable Independent |
to the independent examination ofthe |
examiner for: financial statements |
2,598 | 1,'1 07 |
| 12. | received by t Debtors |
he truste | es. | ||
|---|---|---|---|---|---|
| , ".2020 | 2019 | ||||
| $ | $ | ||||
| Prepayments | and accrued income | 12,030 | 6,630 | ||
| 13. | Creditors: amounts | falling due within one year | |||
| 2020 | 2019 | ||||
| $ | $ | ||||
| Accruals and | deferred | income | 1,386 | 1,050 |
| Unrestricted funds |
|||||
|---|---|---|---|---|---|
| At | |||||
| At | 31 December | ||||
| 1 January 2020 | Income | Expenditure | 2020 | ||
| $ | $ | $ | $ | ||
| General funds | 5,580 | 199,805 | (194,741) | 10,644 | |
| At | |||||
| At | 31 December 2 | ||||
| 1 January 2019 | Income | Expenditure | 019 | ||
| $ | $ | $ | $ | ||
| General funds | 21,475 | 158,022 | (173,917) | 5,580 | |
| Analysis ofnet assets between funds | |||||
| Unrestricted | Total Funds | ||||
| Funds | 2020 | ||||
| $ | $ | ||||
| Current assets | 12,030 | 12,030 | |||
| Creditors less than | 1 year | (1,386) | (1,386) | ||
| Net assets | 10,644 | 10,644 | |||
| Unrestricted | Total Funds | ||||
| Funds | 2019 | ||||
| $ | $ | ||||
| Current assets | 6,630 | 6,630 | |||
| Creditors less than | 1 year | (1,050) | (1,050) | ||
| Net assets | 5,580 | 5,580 |